Wednesday, March 29, 2023

Tag: investigational anti-amyloid beta protofibril


Alzheimer’s drug lecanemab slows cognitive decline in clinical trial

Eisai, a Japanese pharmaceutical company headquartered in Tokyo, and American multinational Biogen have released the results from their phase III clinical trial of lecanemab,...

This function has been disabled for HealthTekPak.

error: Content is protected !!